Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy
Radiolabeled targeting agents have emerged as valuable tools for the treatment of disseminated cancer. Monoclonal antibodies (mAbs) are widely employed as carriers for diagnostic and therapeutic radionuclides due to their exceptional specificity and affinity. However, their prolonged circulatory hal...
Saved in:
Published in | Journal of controlled release Vol. 381; p. 113551 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
10.05.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!